DK292475A - Fremgangsmade til fremstilling af derivater af 3-amino-2-hydroxy-1-phenoxy-propan - Google Patents

Fremgangsmade til fremstilling af derivater af 3-amino-2-hydroxy-1-phenoxy-propan

Info

Publication number
DK292475A
DK292475A DK292475A DK292475A DK292475A DK 292475 A DK292475 A DK 292475A DK 292475 A DK292475 A DK 292475A DK 292475 A DK292475 A DK 292475A DK 292475 A DK292475 A DK 292475A
Authority
DK
Denmark
Prior art keywords
phenoxy
hydroxy
amino
preparing
procedure
Prior art date
Application number
DK292475A
Other languages
English (en)
Other versions
DK143555C (da
DK143555B (da
Inventor
H Demarne
Original Assignee
Cm Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cm Ind filed Critical Cm Ind
Publication of DK292475A publication Critical patent/DK292475A/da
Publication of DK143555B publication Critical patent/DK143555B/da
Application granted granted Critical
Publication of DK143555C publication Critical patent/DK143555C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK292475A 1974-06-28 1975-06-27 Analogifremgangsmaade til fremstilling af 5-fluor-2-(2-hydroxy-3-tert.-butylaminopropoxy)-butyrophenon eller syreadditionssalte eller optisk aktive isomere heraf DK143555C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB28925/74A GB1501632A (en) 1974-06-28 1974-06-28 Aromatic ketones having cardiovascular activity
GB2892574 1974-06-28

Publications (3)

Publication Number Publication Date
DK292475A true DK292475A (da) 1975-12-29
DK143555B DK143555B (da) 1981-09-07
DK143555C DK143555C (da) 1982-02-01

Family

ID=10283421

Family Applications (1)

Application Number Title Priority Date Filing Date
DK292475A DK143555C (da) 1974-06-28 1975-06-27 Analogifremgangsmaade til fremstilling af 5-fluor-2-(2-hydroxy-3-tert.-butylaminopropoxy)-butyrophenon eller syreadditionssalte eller optisk aktive isomere heraf

Country Status (17)

Country Link
US (2) US4252825A (da)
JP (2) JPS5826743B2 (da)
AR (1) AR205388A1 (da)
AT (1) AT343098B (da)
BE (1) BE830766A (da)
CA (1) CA1052820A (da)
CS (1) CS197248B2 (da)
DE (1) DE2528147A1 (da)
DK (1) DK143555C (da)
ES (1) ES438931A1 (da)
FR (1) FR2276032A1 (da)
GB (1) GB1501632A (da)
IE (1) IE41386B1 (da)
NL (1) NL7507703A (da)
SE (2) SE416546B (da)
YU (1) YU165775A (da)
ZA (1) ZA754141B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1501632A (en) * 1974-06-28 1978-02-22 Cm Ind Aromatic ketones having cardiovascular activity
JPH0516363Y2 (da) * 1986-08-01 1993-04-28
AU2003250483A1 (en) 2002-08-19 2004-03-11 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
EA009646B1 (ru) * 2003-05-30 2008-02-28 Рэнбакси Лабораториз Лтд. Замещённые производные пиррола и их применение в качестве ингибиторов hmg-coa
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
JP2009514851A (ja) * 2005-11-08 2009-04-09 ランバクシー ラボラトリーズ リミテッド (3r,5r)−7−[2−(4−フルオロフェニル)−5−イソプロピル−3−フェニル−4−[(4−ヒドロキシメチルフェニルアミノ)カルボニル]−ピロール−1−イル]−3,5−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
TW200744583A (en) * 2006-03-14 2007-12-16 Ranbaxy Lab Ltd Statin stabilizing dosage formulations
BRPI0714361A2 (pt) * 2006-07-14 2013-03-26 Ranbaxy Lab Ltd polimorfo cristalino, composiÇço farmacÊutica contendo o mesmo, mÉtodo para sua preparaÇço e mÉtodo de tratamento
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
BR112021013807A2 (pt) 2019-01-18 2021-11-30 Astrazeneca Ab Inibidores de pcsk9 e seus métodos de uso

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301580A (da) * 1962-12-11
US3637852A (en) * 1963-08-26 1972-01-25 Boehringer Sohn Ingelheim 1-phenoxy-2-hydroxy-3-isopropylamino-propanes and salts thereof
DE1493454C3 (de) * 1963-08-26 1980-04-30 C.H. Boehringer Sohn, 6507 Ingelheim 1 -Aryloxy^-hydroxy-S-isopropylaminopropane und deren Salze sowie deren Herstellung und darauf basierende Arzneimittel
GB1231783A (en) * 1967-05-16 1971-05-12 May & Baker Ltd Benzene derivatives
JPS512115B2 (da) * 1971-09-28 1976-01-23
JPS4911847A (da) * 1972-05-20 1974-02-01
GB1501632A (en) * 1974-06-28 1978-02-22 Cm Ind Aromatic ketones having cardiovascular activity

Also Published As

Publication number Publication date
IE41386B1 (en) 1979-12-19
JPS5123233A (en) 1976-02-24
US4302601A (en) 1981-11-24
CA1052820A (en) 1979-04-17
FR2276032A1 (fr) 1976-01-23
ES438931A1 (es) 1977-05-16
SE416546B (sv) 1981-01-19
ATA497275A (de) 1977-09-15
BE830766A (fr) 1975-12-29
AU8256675A (en) 1977-01-06
FR2276032B1 (da) 1979-08-10
GB1501632A (en) 1978-02-22
YU165775A (en) 1982-02-28
CS197248B2 (en) 1980-04-30
ZA754141B (en) 1976-06-30
JPS5826743B2 (ja) 1983-06-04
JPS58140050A (ja) 1983-08-19
DK143555C (da) 1982-02-01
NL7507703A (nl) 1975-12-30
US4252825A (en) 1981-02-24
JPS5929574B2 (ja) 1984-07-21
DK143555B (da) 1981-09-07
SE417087B (sv) 1981-02-23
IE41386L (en) 1975-12-28
AT343098B (de) 1978-05-10
SE7507359L (sv) 1975-12-29
SE7812646L (sv) 1978-12-08
AR205388A1 (es) 1976-04-30
DE2528147A1 (de) 1976-01-15

Similar Documents

Publication Publication Date Title
DK487475A (da) Fremgangsmade til fremstilling af vandkveldende polyalkylenoxid
DK150155C (da) Analogifremgangsmaade til fremstilling af benzocycloamid-derivater
DK552377A (da) Fremgangsmaade til fremstilling af alfa-beskyttede oxyimino-beta-oxo-gamma-halogen-smoersyrederivater
DK494876A (da) Fremgangsmade til fremstilling af piperidinderivater
DK244875A (da) Fremgangsmade til fremstilling af chromanderivater
DK562376A (da) Fremgangsmade til fremstilling af ergolinderivater
DK239075A (da) Fremgangsmade til fremstilling af iodbenzenderivater
DK462376A (da) Fremgangsmade til fremstilling af 5-halogenpyrimidinderivater
DK292475A (da) Fremgangsmade til fremstilling af derivater af 3-amino-2-hydroxy-1-phenoxy-propan
DK463775A (da) Fremgangsmade til fremstilling af dipeptidderivater
DK351875A (da) Fremgangsmade til fremstilling af 7-methoxy-6-thiatetracyliner
DK223175A (da) Fremgangsmade til fremstilling af pyridobenzodiazepinoner
DK211075A (da) Fremgangsmade til fremstilling af abietamidderivater
DK154890C (da) Fremgangsmaade til fremstilling af 7beta-acylamino-7alfa-alkoxycephalosporiner
DK344175A (da) Fremgangsmade til fremstilling af chromanderivater
DK254275A (da) Fremgangsmade til fremstilling af nye 2-arylamino-2-imidazolinderivater
DK376975A (da) Fremgangsmade til fremstilling af abietamidderivater
DK271975A (da) Fremgangsmade til fremstilling af acylderivater
DK552675A (da) Fremgangsmade til fremstilling af 2-acyl-4-oxopyrazinoisoquinolinderivater
DK198175A (da) Fremgangsmade til fremstilling af indolkinolizidinderivater
DK140576A (da) Fremgangsmade til fremstilling af 21-hydroxy-16-pregnen-20-on-derivater
DK420275A (da) Fremgangsmade til fremstilling af cephemderivater
DK165975A (da) Fremgangsmade til fremstilling af chromenderivater
DK143939C (da) Fremgangsmaade til fremstilling af prostaglandin-fbeta-derivater
DK192576A (da) Fremgangsmade til fremstilling af 7-methoxycephalosporin-derivater

Legal Events

Date Code Title Description
PBP Patent lapsed